Stock Taper
DRTSW
ALPHA TAU MEDICAL LTD.
NASDAQ
$3.79
▼ DOWN 5.25% (-0.21)

KEY STATISTICS

Market Cap$1.46 B
52w High$4.03
52w Low$0.33
Dividend Yield
Frequency
P/E-5.87
Volume77.20K
Shares Out.90.22M

COMPANY

LEADERSHIP

Uzi Sofer
CHIEF EXECUTIVE
Uzi Sofer

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 6, 2026
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
112

UPCOMING EARNINGS

DateNov 24, 2026
DayTuesday
Rev. Est.$368.25K
NOV
24
TUE

PRICE

$3.79 ▼ DOWN 5.25% (−$0.21)
$3.80$3.85$3.9010:01 AM11:00 AM12:00 PM1:00 PM1:59 PM2:58 PM3:58 PM3.79

About Alpha Tau Medical Ltd.

https://www.alphatau.com ↗

Alpha Tau Medical Ltd. is a clinical-stage biotech developing Alpha DaRT, a radiation therapy for solid cancers, with trials for skin, oral, pancreatic, and breast cancers, based in Jerusalem and operating in Israel and the U.S.

INDUSTRY

Biotechnology

A PRODUCT ALPHA TAU MEDICAL LTD. IS KNOWN FOR

Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy)
Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy)

Alpha DaRT is a radiation therapy that uses radium-224 sources to deliver alpha particles directly into tumors, destroying cancer cells while sparing healthy tissue, and is currently in clinical trials.

COMPETITORS

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

OFFICER: CHIEF FINANCIAL OFFICER
Levy Raphi
Purchase · 2.9K shares
2026-08-21
OFFICER: CHIEF FINANCIAL OFFICER
Levy Raphi
Purchase · 17.7K shares
2026-08-11
OFFICER: CHIEF FINANCIAL OFFICER
Levy Raphi
Purchase · 2.3K shares
2026-07-06
OFFICER: CHIEF FINANCIAL OFFICER
Levy Raphi
Purchase · 17.9K shares
2026-07-02

SECTORS PEERS

PEERPRICE
NRXS$6.00COMPARE
BOLD$2.83COMPARE
ENLV$1.35COMPARE
NRSN$0.42COMPARE
PASG$4.52COMPARE
CVKD$1.54COMPARE
CLGN$0.36COMPARE